Session Chair Profile
M.S., Global Marketing Director – Cancer Genetics, Agilent Technologies
Rebecca is responsible for the strategic direction and day to day management of cancer genetics, NGS technology and molecular pathology teams. Rebecca joined Agilent in July of 2014 bringing more than 20 years of expertise gained from leading companies in life sciences, diagnostics and routine clinical testing. She received a Master’s Degree in Molecular Genetics from Wake Forest University. Prior to joining QIAGEN, Asuragen and Affymetrix to lead their marketing programs, Rebecca spent several years running a high-throughput, clinical molecular oncology laboratory.
Session Synopsis: This session will describe two institutions’ experiences with implementing precision technologies such as NGS for the genetic profiling of cancer, as well as show how a multi-modal approach to understanding cancer ultimately improves care.